Brief: ALZpath Inc - Signs Licensing Agreement with Siemens Healthineers

Siemens Healthineers AG

15/12/2025 13:40

Dec 15 (Reuters) - ALZPATH INC:

ALZPATH AND SIEMENS HEALTHINEERS SHLG.DE SIGN LICENSING AGREEMENT TO ADVANCE GLOBAL ACCESS TO BLOOD-BASED ALZHEIMER'S DISEASE DIAGNOSTIC TESTING

LICENSING FOR USE OF ITS PROPRIETARY PTAU217 ANTIBODY IN DEVELOPMENT OF A PTAU217 ASSAY IN EXPANDING MENU OF SIEMENS HEALTHINEERS IN VITRO DIAGNOSTIC (IVD) TESTS FOR ALZHEIMER'S DISEASE

Source text: ID:nPn4MH6yHa

Further company coverage: []

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 587785269;))